Why the study?
Does combined anticoagulant and antiselectin treatment prevent lethal intravascular coagulation in a murine model of DIC?
Does combined anticoagulant and antiselectin treatment prevent lethal intravascular coagulation in a murine model of DIC?
Combined blockade of leukocyte/platelet adhesion and coagulation provides protection against lethal intravascular coagulation in a murine model of DIC.
Answers are grounded in this paper and cite their sources.
Protects mice from lethal DIC; hypothesis-generating for combined antiselectin-anticoagulant strategies in humans.
Widespread microvascular injury followed by vessel obstruction may lead to disseminated intravascular coagulation (DIC). We describe a murine model wherein leukocytes interacting with inflamed microvessels in vivo are activated by antibodies. Treatment of tumor necrosis factor alpha (TNF-alpha)-primed mice with anti-Ly-6G antibodies reproduced many of the features of septic or traumatic shock including microvessel obstruction and coagulation, severe vasculitis, respiratory difficulties, and vascular leakage. Mice lacking either E-selectin or P-selectin were protected from this reaction as were animals treated with a combination of either selectin-blocking antibodies and heparin or a selectin antagonist plus heparin. Combined blockade of leukocyte/platelet adhesion and coagulation may provide convincing protection in DIC.
No takes yet. Share an insight, caveat, or question.
Norman et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: